|BMO Capital Markets||Jim Birchenough, M.D.|
|Canaccord Equity||Ritu Baral|
|Stifel Nicolaus||Stephen Willey|
Tranzyme Pharma is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Tranzyme Pharma's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Tranzyme Pharma or its management. Tranzyme Pharma does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.